{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:33:50Z","timestamp":1791412430560,"version":"4.3.3"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jocd.2026.101685","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:20:28Z","timestamp":1771546828000},"page":"101685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personalized treatment pathways for adult osteomalacia"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-9687","authenticated-orcid":false,"given":"Maroua","family":"Slouma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Bettaieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-8653","authenticated-orcid":false,"given":"Safa","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhem","family":"Cheour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounir","family":"Lamloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jocd.2026.101685_bib0001","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.3390\/jcm12072714","article-title":"Osteomalacia in adults: a practical insight for clinicians","volume":"12","author":"Arboleya","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jocd.2026.101685_bib0002","article-title":"Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: a pooled analysis of 7.9 million participants","volume":"10","author":"Cui","year":"2023","journal-title":"Front Nutr [Internet]"},{"issue":"5","key":"10.1016\/j.jocd.2026.101685_bib0003","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/phpp.12590","article-title":"Rickets in association with skin diseases and conditions: a review with emphasis on screening and prevention","volume":"36","author":"Litaiem","year":"2020","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"6","key":"10.1016\/j.jocd.2026.101685_bib0004","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4158\/EP09050.ORR","article-title":"Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity","volume":"15","author":"Al-Shoha","year":"2009","journal-title":"Endocr Pr"},{"key":"10.1016\/j.jocd.2026.101685_bib0005","series-title":"Williams Textbook of Endocrinology","first-page":"1298","article-title":"Rickets and Osteomalacia","author":"Bhan","year":"2019"},{"issue":"10","key":"10.1016\/j.jocd.2026.101685_bib0006","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.mpmed.2013.07.012","article-title":"Rickets and osteomalacia","volume":"41","author":"Whyte","year":"2013","journal-title":"Med (Baltim)"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0007","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/ijmr.IJMR_1961_19","article-title":"Nutritional rickets & osteomalacia: A practical approach to management","volume":"152","author":"Uday","year":"2020","journal-title":"Indian J Med Res"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0008","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11154-021-09693-7","article-title":"Vitamin D: dosing, levels, form, and route of administration: does one approach fit all?","volume":"22","author":"Bilezikian","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10.1016\/j.jocd.2026.101685_bib0009","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","article-title":"Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis","volume":"95","author":"Tripkovic","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jocd.2026.101685_bib0010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0115426507022003286","article-title":"Calcium supplementation in clinical practice: a review of forms, doses, and indications","volume":"22","author":"Straub","year":"2007","journal-title":"Nutr Clin Pr"},{"issue":"10","key":"10.1016\/j.jocd.2026.101685_bib0011","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/jn\/135.10.2379","article-title":"Calcium bioavailability of calcium carbonate fortified soymilk is equivalent to cow\u2019s milk in young women","volume":"135","author":"Zhao","year":"2005","journal-title":"J Nutr"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0012","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/j.ajkd.2012.03.024","article-title":"Approach to treatment of hypophosphatemia","volume":"60","author":"Felsenfeld","year":"2012","journal-title":"Am J Kidney Dis J Natl Kidney Found"},{"issue":"9","key":"10.1016\/j.jocd.2026.101685_bib0013","doi-asserted-by":"crossref","first-page":"bvab099","DOI":"10.1210\/jendso\/bvab099","article-title":"Diagnosis and management of tumor-induced osteomalacia: perspectives from clinical experience","volume":"5","author":"Dahir","year":"2021","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.jocd.2026.101685_bib0014","first-page":"879","article-title":"A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets","volume":"75","author":"Sullivan","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2026.101685_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154049","article-title":"Management of X-linked hypophosphatemia in adults","volume":"103","author":"Lecoq","year":"2020","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jocd.2026.101685_bib0016","first-page":"20","article-title":"Basic and clinical aspects of calcimimetics. Cinacalcet, effect and mechanisms of action]","volume":"18","author":"Nakanishi","year":"2008","journal-title":"Clin Calcium"},{"issue":"6","key":"10.1016\/j.jocd.2026.101685_bib0017","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","article-title":"Cinacalcet in the management of tumor-induced osteomalacia","volume":"22","author":"Geller","year":"2007","journal-title":"J Bone Min Res J Am Soc Bone Min Res"},{"issue":"1","key":"10.1016\/j.jocd.2026.101685_bib0018","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/mrcr\/rxab031","article-title":"X-linked hypophosphataemic rickets: report of a novel PHEX mutation and cinacalcet as adjuvant therapy in the mineral metabolism control","volume":"6","author":"Cavaco","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"issue":"50","key":"10.1016\/j.jocd.2026.101685_bib0019","doi-asserted-by":"crossref","first-page":"31800","DOI":"10.1073\/pnas.2018554117","article-title":"FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with \u03b1-Klotho","volume":"117","author":"Suzuki","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10.1016\/j.jocd.2026.101685_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10190","article-title":"FGF23, hypophosphatemia, and emerging treatments","volume":"3","author":"Imel","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/j.jocd.2026.101685_bib0021","series-title":"FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia [Internet]","year":"2020"},{"issue":"8","key":"10.1016\/j.jocd.2026.101685_bib0022","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Min Res J Am Soc Bone Min Res"},{"issue":"12","key":"10.1016\/j.jocd.2026.101685_bib0023","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial","volume":"34","author":"Insogna","year":"2019","journal-title":"J Bone Min Res J Am Soc Bone Min Res"},{"issue":"3","key":"10.1016\/j.jocd.2026.101685_bib0024","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"10.1016\/j.jocd.2026.101685_bib0025","first-page":"1217","article-title":"[Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia]","volume":"24","author":"Kinoshita","year":"2014","journal-title":"Clin Calcium"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0026","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Min Res J Am Soc Bone Min Res"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0027","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"issue":"14","key":"10.1016\/j.jocd.2026.101685_bib0028","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMc2020399","article-title":"Targeted FGFR blockade for the treatment of tumor-induced osteomalacia","volume":"383","author":"Hartley","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jocd.2026.101685_bib0029","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Jc","year":"2016","journal-title":"Mod Pathol J U S Can Acad Pathol Inc"},{"issue":"8","key":"10.1016\/j.jocd.2026.101685_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10661","article-title":"Infigratinib reduces fibroblast growth factor 23 (FGF23) and increases blood phosphate in tumor-induced osteomalacia","volume":"6","author":"Hartley","year":"2022","journal-title":"JBMR Plus"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0031","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ophtha.2020.08.026","article-title":"Ocular adverse effects of infigratinib, a new fibroblast growth factor receptor tyrosine kinase inhibitor","volume":"128","author":"Magone","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jocd.2026.101685_bib0032","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.2147\/DDDT.S154922","article-title":"Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy","volume":"12","author":"Bowden","year":"2018","journal-title":"Drug Devel Ther [Internet]"},{"issue":"9","key":"10.1016\/j.jocd.2026.101685_bib0033","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1210\/js.2017-00307","article-title":"Successful Asfotase alfa treatment in an adult dialysis patient with childhood-onset hypophosphatasia","volume":"1","author":"Remde","year":"2017","journal-title":"J Endocr Soc"},{"issue":"10","key":"10.1016\/j.jocd.2026.101685_bib0034","first-page":"1503","article-title":"[Updates on rickets and osteomalacia: surgical treatment for rickets\/osteomalacia]","volume":"23","author":"Kawano","year":"2013","journal-title":"Clin Calcium"},{"key":"10.1016\/j.jocd.2026.101685_bib0035","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-020-05795-1","article-title":"Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation","author":"Horng","year":"2021","journal-title":"Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"},{"issue":"1","key":"10.1016\/j.jocd.2026.101685_bib0036","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/CH-200921","article-title":"Application of ultrasound-guided biopsy and percutaneous radiofrequency ablation in 2 cases with phosphaturic mesenchymal tumor and literature review","volume":"77","author":"Xian","year":"2021","journal-title":"Clin Hemorheol Microcirc"},{"issue":"9","key":"10.1016\/j.jocd.2026.101685_bib0037","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/jc.2013-4515","article-title":"Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients","volume":"99","author":"Jadhav","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2026.101685_bib0038","article-title":"Successful treatment of tumor-induced osteomalacia by multidisciplinary therapy with radiation to intracranial fibromyxoid tumor","volume":"2021","author":"Massaccesi","year":"2021","journal-title":"Case Rep Endocrinol"},{"issue":"7","key":"10.1016\/j.jocd.2026.101685_bib0039","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.jocd.2026.101685_bib0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0041","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5603\/EP.2013.0012","article-title":"Practical guidelines for the supplementation of vitamin D and the treatment of deficits in central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency","volume":"64","author":"P\u0142udowski","year":"2013","journal-title":"Endokrynol Pol"},{"issue":"7","key":"10.1016\/j.jocd.2026.101685_bib0042","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jocd.2026.101685_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2025.105858","article-title":"Daily or intermittent vitamin D supplementation in patients with or at risk of osteoporosis: Position statement from the GRIO","volume":"92","author":"Pickering","year":"2025","journal-title":"Jt Bone Spine"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0044","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1210\/clinem\/dgz212","article-title":"Safety of high-dose vitamin D supplementation: secondary analysis of a randomized controlled trial","volume":"105","author":"Billington","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2026.101685_bib0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jsbmb.2017.01.021","article-title":"Vitamin D supplementation guidelines","volume":"175","author":"Pludowski","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"10.1016\/j.jocd.2026.101685_bib0046","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/clinem\/dgae290","article-title":"Vitamin D for the prevention of disease: an endocrine society clinical practice guideline","volume":"109","author":"Demay","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.jocd.2026.101685_bib0047","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.3390\/nu13124415","article-title":"Vitamin D dosing: basic principles and a brief algorithm (2021 update)","volume":"13","author":"Bleizgys","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jocd.2026.101685_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10447","article-title":"Osteomalacia and Vitamin D Status: A Clinical Update 2020","volume":"5","author":"Minisola","year":"2021","journal-title":"JBMR Plus"},{"issue":"2","key":"10.1016\/j.jocd.2026.101685_bib0049","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ecl.2010.02.001","article-title":"Osteomalacia as a result of vitamin D deficiency","volume":"39","author":"Bhan","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 2","key":"10.1016\/j.jocd.2026.101685_bib0050","first-page":"88","article-title":"Genetic causes of rickets","volume":"9","author":"Acar","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.jocd.2026.101685_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.00315","article-title":"Diagnosis and management of vitamin D dependent rickets","volume":"8","author":"Levine","year":"2020","journal-title":"Front Pediatr"},{"issue":"7864","key":"10.1016\/j.jocd.2026.101685_bib0052","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(74)91265-3","article-title":"Magnesium-dependent vitamin-D-resistant rickets","volume":"303","author":"Reddy","year":"1974","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jocd.2026.101685_bib0053","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.eprac.2022.07.005","article-title":"Hypophosphatemia: a practical guide to evaluation and management","volume":"28","author":"Tebben","year":"2022","journal-title":"Endocr Pr"},{"issue":"6","key":"10.1016\/j.jocd.2026.101685_bib0054","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong","year":"2013","journal-title":"J Bone Min Res J Am Soc Bone Min Res"},{"issue":"1","key":"10.1016\/j.jocd.2026.101685_bib0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","article-title":"Tumor-induced osteomalacia","volume":"108","author":"Florenzano","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.jocd.2026.101685_bib0056","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous dysplasia\/mccune-albright syndrome: a rare, mosaic disease of G\u03b1\u200as activation","volume":"41","author":"Boyce","year":"2019","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.jocd.2026.101685_bib0057","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/clinem\/dgac518","article-title":"Long-term burosumab administration is safe and effective in adults with X-linked hypophosphatemia","volume":"108","author":"Weber","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jocd.2026.101685_bib0058","article-title":"Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review","volume":"9","author":"Mp","year":"2010","journal-title":"Horm Athens Greece"},{"key":"10.1016\/j.jocd.2026.101685_bib0059","article-title":"Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with X-linked dominant hypophosphatemic rickets: a case report","volume":"2014","author":"Grove-Laugesen","year":"2014","journal-title":"Case Rep Endocrinol"},{"issue":"16","key":"10.1016\/j.jocd.2026.101685_bib0060","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.3390\/ijerph18168771","article-title":"Autosomal dominant hypophosphatemic rickets: a case report and review of the literature","volume":"18","author":"Mameli","year":"2021","journal-title":"Int J Env Res Public Health"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0061","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.070107","article-title":"FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets","volume":"22","author":"Imel","year":"2007","journal-title":"J Bone Min Res J Am Soc Bone Min Res"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0062","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","article-title":"Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease","volume":"23","author":"Wolf","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"9","key":"10.1016\/j.jocd.2026.101685_bib0063","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1210\/jc.2015-2391","article-title":"Iron supplementation associated with loss of phenotype in autosomal dominant hypophosphatemic rickets","volume":"100","author":"Kapelari","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2026.101685_bib0064","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jbmr.3878","article-title":"Oral iron replacement normalizes fibroblast growth factor 23 in iron-deficient patients with autosomal dominant hypophosphatemic rickets","volume":"35","author":"Imel","year":"2020","journal-title":"J Bone Min Res J Am Soc Bone Min Res"},{"key":"10.1016\/j.jocd.2026.101685_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116111","article-title":"Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) due to ENPP1-deficiency","volume":"153","author":"H\u00f6ppner","year":"2021","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jocd.2026.101685_bib0066","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bone.2009.09.016","article-title":"Identification of a novel dentin matrix protein-1 (DMP-1) mutation and dental anomalies in a kindred with autosomal recessive hypophosphatemia","volume":"46","author":"Turan","year":"2010","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.jocd.2026.101685_bib0067","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/s41436-021-01228-4","article-title":"Correspondence on \u201cProspective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)\u201d by Ferreira et al","volume":"23","author":"Stern","year":"2021","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.jocd.2026.101685_bib0068","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00424-018-2184-2","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy","volume":"471","author":"Bergwitz","year":"2019","journal-title":"Pflug Arch"},{"issue":"2","key":"10.1016\/j.jocd.2026.101685_bib0069","first-page":"376","article-title":"Japanese Dent disease has a wider clinical spectrum than dent disease in Europe\/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria","volume":"29","author":"Sekine","year":"2014","journal-title":"Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"24","key":"10.1016\/j.jocd.2026.101685_bib0070","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.2169\/internalmedicine.1272-18","article-title":"Severe osteomalacia with dent disease caused by a novel intronic mutation of the CLCN5 gene","volume":"57","author":"Matsumoto","year":"2018","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0071","first-page":"303","article-title":"Fanconi syndrome in the adulthood. the role of early diagnosis and treatment","volume":"17","author":"Karatzas","year":"2017","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"8","key":"10.1016\/j.jocd.2026.101685_bib0072","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10215","article-title":"Outcome of teriparatide treatment on fracture healing complications and symptomatic bone marrow edema in four adult patients with hypophosphatasia","volume":"3","author":"Schmidt","year":"2019","journal-title":"JBMR Plus"},{"issue":"4","key":"10.1016\/j.jocd.2026.101685_bib0073","first-page":"491","article-title":"Osteomalacia as a result of urinary diversion","volume":"13","author":"Bilge","year":"2017","journal-title":"Acta Endocrinol Buchar Rom 2005"},{"issue":"1","key":"10.1016\/j.jocd.2026.101685_bib0074","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.abb.2010.07.021","article-title":"Acidosis, hypoxia and bone","volume":"503","author":"Arnett","year":"2010","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10.1016\/j.jocd.2026.101685_bib0075","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1210\/jc.2016-3055","article-title":"Fibrogenesis imperfecta ossium and response to human growth hormone: a potential therapy","volume":"102","author":"Bhadada","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2026.101685_bib0076","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bonekey.2014.24","article-title":"Bisphosphonates and bone quality","volume":"3","author":"Pazianas","year":"2014","journal-title":"BoneKEy Rep"},{"issue":"5","key":"10.1016\/j.jocd.2026.101685_bib0077","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ki.1992.198","article-title":"Effect of fluoride on aluminum-induced bone disease in rats with renal failure","volume":"41","author":"Ittel","year":"1992","journal-title":"Kidney Int"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695026000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695026000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:14:35Z","timestamp":1776204875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695026000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1094695026000193"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2026.101685","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalized treatment pathways for adult osteomalacia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2026.101685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101685"}}